Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: allopurinol

ACR Releases Guidelines for Gout Management

Kathy Holliman  |  October 1, 2012

The American College of Rheumatology’s two-part guidelines stress the need for treating to target, more aggressive management, and therapy

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorycrystal arthritisdrugGoutGuidelinespatient careprednisonerheumatologist

Ethics Forum: The Ethical Pitfalls of Clinical Trials

Robert H. Shmerling, MD  |  April 6, 2012

Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.

Filed under:EthicsProfessional TopicsResearch Rheum Tagged with:clinical trialsdrugEthicsMethotrexateResearchRheumatoid arthritisrheumatologist

Information on New Drug Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP  |  March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:anti-inflammatoryBiologicscrystal arthritisdrugGoutJAK inhibitorsjanus kinaseMethotrexateRheumatoid arthritisrheumatologistSafetyTofacitinib

Coding Corner: February’s Coding Challenge

Staff  |  February 3, 2012

A 62-year-old male patient returns to the office for a followup visit for his gout.

Filed under:Billing/CodingConditionsGout and Crystalline ArthritisPractice Support Tagged with:BillingCancerCodingcrystal arthritisE&MGoutlabsPractice Managementrheumatologist

A Walk in the Windy City

David S. Pisetsky, MD, PhD  |  December 12, 2011

A final column full of many thanks and a few parting thoughts

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:AC&Rrheumatologist

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 12, 2011

Information on New Approvals and Medication Safety

Filed under:AnalgesicsDrug Updates Tagged with:ApprovalsDrugsFDAPipelineSafety

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 16, 2011

Information on New Approvals and Medication Safety

Filed under:AnalgesicsDrug Updates Tagged with:ApprovalsDrugsFDAPipelineSafetyshortage

Drug UPDATES

Michele B. Kaufman, PharmD, BCGP  |  March 18, 2011

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsFDASafety

Letter to the Editor

Alan Zalkowitz, MD  |  November 1, 2010

Feedback from our Readers

Filed under:ConditionsGout and Crystalline ArthritisOther Rheumatic Conditions Tagged with:Aggressive Urate LoweringGoutTreatment

Tear Down That Wall: CME restrictions stifle speeches

Bruce N. Cronstein, MD  |  August 1, 2010

The Nobel Peace Prize is one of the most prestigious awards in the world because it recognizes individuals and organizations that promote the causes of peace and human rights. In 1991, Aung San Suu Kyi received this prize for her courageous work in advancing democracy in the Republic of Myanmar. Because of her leadership of the democracy movement in Myanmar, the military regime that governs that country has gone to great lengths to gag her. Indeed, she has been under house arrest for most of the last two decades since she received the Peace Prize. An outpouring of support for Aung San Suu Kyi and demands for her freedom by human rights advocates and Western governments have sadly been to no avail.

Filed under:Education & TrainingProfessional TopicsProfiles Tagged with:Conflict of interestEducationIndustry

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences